PPARs: Transcriptional effectors of fatty acids and their derivatives

Cellular and Molecular Life Sciences

Volumn 59, Issue 5, 2002, Pages 790-798

  Hihi, A K ^a   Michalik, L ^a   Wahli, W ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Differentiation; Eicosanoids; Fatty acid catabolism; Ligand; Nuclear receptors; Peroxisome proliferator activated receptor; Thiazolidinediones; Transcription

Indexed keywords

FATTY ACID; FATTY ACID DERIVATIVE; HORMONE RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID; THYROID HORMONE; UNCLASSIFIED DRUG;

ADIPOCYTE; APOPTOSIS; CATABOLISM; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CRYSTALLOGRAPHY; ENDOCRINE CELL; ENDOCRINE FUNCTION; GENETIC TRANSCRIPTION; INFLAMMATION; LIGAND BINDING; MONOCYTE; NIDATION; PROTEIN DOMAIN; REVIEW;

ANIMALS; DNA-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0036283121     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8467-x     Document Type: Review

References (84)

1. Regulation of gene expression by fatty acids and fibric acid derivatives: An integrative role for peroxisome proliferator activated receptors
2. The peroxisome proliferator-activated receptors at the crossroad of diet and hormonal signalling
3. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
4. The nuclear receptor superfamily: The second decade
5. Superfamily of steroid nuclear receptors: Positive and negative regulators of gene expression
6. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
7. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
8. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor
9. cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor
10. A unified nomenclature system for the nuclear receptor superfamily
11. The steroid and thyroid hormone receptor superfamily
12. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent transactivating domain
13. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma
14. Solution structure of the DNA-binding domain of the oestrogen receptor
15. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
16. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
17. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
18. Role of CBP/P300 in nuclear receptor signalling
19. p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha
20. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
21. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor
22. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
23. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
24. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
25. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
26. The pleiotropic functions of peroxisome proliferator-activated receptor gamma
27. A canonical structure for the ligand-binding domain of nuclear receptors
28. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors
29. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
30. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma
31. A structural role for hormone in the thyroid hormone receptor
32. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor
33. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes
34. Peroxisome proliferator-activated receptors and lipid metabolism
35. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
36. Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4)
37. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change
38. Ligand selectivity of the peroxisome proliferator-activated receptor alpha
39. The PPARalpha-leukotriene B4 pathway to inflammation control
40. Inflammation. Signalling the fat controller
41. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice
42. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
43. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
44. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer
45. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)
46. Critical roles of PPARbeta/delta in keratinocyte response to inflammation
47. Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family
48. Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library
49. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
50. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects
51. PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents
52. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
53. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta and -gamma in the adult rat
54. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta and -gamma during rat embryonic development
55. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
56. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
57. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha
58. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
59. Peroxisome proliferator-activated receptor agonists
60. Troglitazone action is independent of adipose tissue
61. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
62. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
63. The nuclear receptor PPARgamma - Bigger than fat
64. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
65. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
66. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
67. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
68. PPARgamma induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
69. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
70. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma
71. Terminal differentiation of human breast cancer through PPAR gamma
72. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
73. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
74. PPAR tissue distribution and interactions with other hormone-signaling pathways
75. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: Cross talk between peroxisome proliferator and T3 signaling pathways
76. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat
77. Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resistance
78. Cloning and expression of a cDNA for mouse prostaglandin F receptor
79. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma
80. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
81. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
82. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha
83. The LXRs: A new class of oxysterol receptors
84. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis